Feed ATEC
AT

Alphatec Holdings, Inc.

ATEC · NASDAQ

$10.18 -0.59% (-$0.06)
1M +10.17%
Market Cap $1.57B
P/E Ratio -
Div. Yield -
ROE -

Bulios Fair Price

$13.63

33.9% upside

Trenutna cena

$10.18

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica ATEC trenutno podcenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Moderate
5/9
Valuation
13 /100
Expensive
EV/EBITDA 152.42x
P/S 1.92x
P/FCF 376.70x
Growth
100 /100
Growing
Rev. growth 29.62%
EPS growth N/A
FCF growth N/A
Profitability
23 /100
Weak
Gross margin 66.15%
Net margin 13.50%
Op. margin 5.55%
Quality
18 /100
Poor
ROIC 7.55%
ROA 13.91%
Asset turnover 1.03x
Debt
20 /100
High
Current ratio 1.89x
Int. coverage -1.69x
Net debt/EBITDA 36.07x
Stability
85 /100
Stable
Beta 0.85x
Rev. volatility 6.74%
EPS volatility 15.87%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o ATEC
Online

O podjetju

Alphatec Holdings (ATEC) is an American company focused on the development and manufacturing of innovative medical devices and implants in the field of orthopedics and neurosurgery. Their products include a wide range of tools and implants for spine surgeries, including technologies based on artificial intelligence and 3D printing. Alphatec Holdings aims to provide comprehensive solutions for surgeons and patients, incorporating the latest technological innovations and procedures.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Devices

CEO

Patrick S. Miles

Employees

913

Headquarters

Carlsbad

Prihajajoči dogodki

29 OKT.

Earnings

Upcoming earnings report

38d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.